Human safety risk assessment of lymph node angiomas observed in 2-year carcinogenicity studies in rats

Regulatory Toxicology and Pharmacology

Volumn 64, Issue 3, 1970, Pages 435-441

  Radi, Zaher A ^a   Morton, Daniel ^a  

^a PFIZER INC   (United States)

Author keywords

Angioma; Carcinogenicity; Human safety risk assessment; Lymph node; Lymphangioma; Rat

Indexed keywords

ACETIC ACID DERIVATIVE; ALKENE DERIVATIVE; CITRAL; DRONEDARONE; LAPATINIB; NICKEL SULFATE; ORGANOCHLORINE DERIVATIVE; TERT BUTYLHYDROQUINONE; DRUG;

ARTICLE; CARCINOGENESIS; CARCINOGENICITY; CLINICAL FEATURE; DISEASE COURSE; GENOTOXICITY; HEMANGIOMA; INCIDENCE; LYMPHANGIOMA; MESENTERY LYMPH NODE; NONHUMAN; PATHOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; TOXIC CONCENTRATION; TOXICITY TESTING; ANIMAL; DRUG DESIGN; FEMALE; HUMAN; LYMPH NODE; MALE; MESENTERY; METHODOLOGY; MOUSE; RAT; SPECIES DIFFERENCE;

ANIMALS; DRUG DESIGN; FEMALE; HEMANGIOMA; HUMANS; LYMPH NODES; LYMPHANGIOMA; MALE; MESENTERY; MICE; PHARMACEUTICAL PREPARATIONS; RATS; RISK ASSESSMENT; SEX FACTORS; SPECIES SPECIFICITY;

EID: 84868472485     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2012.10.006     Document Type: Article

References (46)

1. Almagro, U.A., Choi, H., Rouse, T.M., Hemangioma in a lymph node. Arch. Pathol. Lab. Med. 109 (1985), 576–578.
2. Chan, J.K., Frizzera, G., Fletcher, C.D., Rosai, J., Primary vascular tumors of lymph nodes other than Kaposi's sarcoma. Analysis of 39 cases and delineation of two new entities. Am. J. Surg. Pathol. 16 (1992), 335–350.
3. Chan, J.K., Warnke, R.A., Dorfman, R., Vascular transformation of sinuses in lymph nodes. A study of its morphological spectrum and distinction from Kaposi's sarcoma. Am. J. Surg. Pathol. 15 (1991), 732–743.
4. CDER, 2005. NDA 22-425, Dronedarone, FDA Statistical Review Evaluation. < http://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022425s000_StatR.pdf> (accessed 14.02.12.).
5. CDER NDA 22-059, 2007. Tykerb, lapatinib ditosylate tablet. Pharmacology Review. Accessed electronically at: < http://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/022059s000TOC.cfm>.
6. Cohen, S.M., Storer, R.D., Criswell, K.A., Doerrer, N.G., Dellarco, V.L., Pegg, D.G., Wojcinski, Z.W., Malarkey, D.E., Jacobs, A.C., Klaunig, J.E., Swenberg, J.A., Cook, J.C., Hemangiosarcoma in rodents: mode-of-action evaluation and human relevance. Toxicol. Sci. 111 (2009), 4–18.
7. Deerberg, F., Rapp, K., Rehm, S., Pittermann, W., Genetic and environmental influences on lifespan and diseases in Han:Wistar rats. Mech. Agening Dev. 14 (1980), 333–343.
8. Dellachà A., Fulcheri, E., Campisi, C., A lymph nodal capillary-cavernous hemangioma. Lymphology 32 (1999), 123–125.
9. Elgoweini, M., Chetty, R., Primary nodal hemangioma. Arch. Pathol. Lab. Med. 136 (2012), 110–112.
10. Elmore, S.A., Histopathology of the lymph nodes. Toxicol. Pathol. 34 (2006), 425–454.
11. Giknis, M., Clifford, C., 2004. Compilation of spontaneous neoplastic lesions and survival in Crl:CD (SD) rats from control groups. Charles River Laboratories. < http://www.criver.com/SiteCollectionDocuments/rm_rm_r_lesions_survival_crlcd_sd_rats.pdf> (accessed 27.03.12.).
12. Giknis, M., Clifford, C., 2011. Neoplastic and non-neoplastic lesions in the Charles River Wistar Hannover [Crl:WI(Han)] rat. Charles River Laboratories. < http://www.criver.com/SiteCollectionDocuments/rm_rm_r_Wistar_Han_Tox_Data_2011.pdf> (accessed 27.03.12.).
13. Haferkamp, O., Rosenau, W., Lennert, K., Vascular transformation of lymph node sinuses due to venous obstruction. Arch. Pathol. 92 (1971), 81–83.
14. Hardisty, J.F., Elwell, M.R., Greaves, P., Kolenda-Roberts, H., Malarkey, D.E., Mnn, P.C., Tellier, P.A., Histopathology of hemangiosarcomas in mice and hamsters and liposarcomas/fibrosarcomas in rats associated with PPAR agonists. Toxicol. Pathol. 35 (2007), 928–941.
15. Har-El, G., Heffner, D.K., Ruffy, M., Haemangioma in a cervical lymph node. J. Laryngol. Otol. 104 (1990), 513–515.
16. Haseman, J.K., Hailey, J.R., Morris, R.W., Spontaneous neoplasm incidences in Fischer 344 rats and B6C3F1 mice in two-year carcinogenicity studies: a National Toxicology Program update. Toxicol. Pathol. 26 (1998), 428–441.
17. International Conference on Harmonization (ICH), 2008. International Conference on Harmonization. S2 (R1) Genotoxicity Testing and Data Interpretation for Pharmaceuticals Intended for Human Use. Available at: < http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Safety/S2_R1/Step4/S2R1_Step4.pdf> (accessed 17.04.12.).
18. Kaspareit, A., Rittinghausen, S., Spontaneous neoplastic lesions in Harlan Sprague–Dawley rats. Exp. Toxicol. Pathol. 51 (1999), 105–107.
19. Kasznica, J., Sideli, R.V., Collins, M.H., Lymph node hemangioma. Arch. Pathol. Lab. Med. 113 (1989), 804–807.
20. Kraal, G., Schornagel, K., Savelkoul, H., Maruyama, T., Activation of high endothelial venules in peripheral lymph nodes. The involvement of interferon-gamma. Int. Immunol. 6 (1994), 1195–1201.
21. Lapatinib ditosylate (Tykerb™) Product Monograph, 2011. < http://www.gsk.ca/english/docs-pdf/product-monographs/Tykerb.pdf> (accessed 14.02.12.).
22. Mancardi, S., Stanta, G., Dusetti, N., Bestagno, M., Jussila, L., Zweyer, M., Lunazzi, G., Dumont, D., Alitalo, K., Burrone, O.R., Lymphatic endothelial tumors induced by intraperitoneal injection of incomplete Freund's adjuvant. Exp. Cell Res. 246 (1999), 368–375.
23. Muller, L., In-vitro genotoxicity tests to detect carcinogenicity: a systemic review. Hum. Exp. Toxicol. 28 (2009), 131–133.
24. Nambiar, P.R., Turnquist, S.E., Morton, D., Spontaneous tumor incidence in rasH2 mice. Review of internal data and published literature. Toxicol. Pathol. 40 (2012), 614–623.
25. National Toxicology Program, 2012. Bioassay Pathology Study Data Searches. https://ntpps.niehs.nih.gov/iacf/demo/FinalmorNeoOrgan.cfm?topid=25452&top=Lymph Node, Mesenteric&morid=142 (accessed 21.02.12.).
26. National Toxicology Program, 1993. Toxicology and carcinogenesis studies of 1,2,3-trichloropropane (CAS NO. 96-18-4) in F344/N rats and B6C3F1 mice (gavage study). NTP Technical Report No. 384. Research Triangle Park, NC 27709, U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health.
27. National Toxicology Program. NTP toxicology and carcinogenesis studies of nickel sulfate hexahydrate (CAS No. 10101-97-0) in F344 rats and B6C3F1 mice (inhalation studies). Natl. Toxicol. Program Tech. Rep. Ser. 454 (1996), 1–380.
28. National Toxicology Program. NTP toxicology and carcinogenesis studies of hydroquinone (CAS No. 123-31-9) in F344/N rats and B6C3F1 mice (gavage studies). Natl. Toxicol. Program Tech. Rep. Ser. 366 (1989), 1–248.
29. National Toxicology Program. Toxicology and carcinogenesiss studies of citral (microencapsulated) (CAS No. 5392-40-5) in F344/N rats and B6C3F1 mice (feed studies). Natl. Toxicol. Program Tech. Rep. Ser. 505 (2003), 1–268.
30. National Toxicology Program. Toxicology and carcinogenesis studies of dibromoacetic acid (Cas No. 631-64-1) in F344/N rats and B6C3F1 mice (drinking water studies). Natl. Toxicol. Program Tech. Rep. Ser. 537 (2007), 1–320.
31. Ohtani, O., Ohtani, Y., Structure and function of rat lymph nodes. Arch. Histol. Cytol. 71 (2008), 69–76.
32. Pagni, F., Di Bella, C., Capillary cavernous hemangioma of lymph node. Int. J. Surg. Pathol., 18, 2010, 338.
33. Ram, M., Alsanjari, N., Ansari, N., Angiomyomatous hamartoma: a rare case report with review of the literature. Rare Tumors., 1, 2009, e25.
34. Reich, R.F., Moss, S., Freedman, P.D., Intranodal hemangioma of the oral soft tissues: a case report of a rare entity with review of the literature. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 90 (2000), 71–73.
35. Reindel, J.F., Dominick, M.A., Gough, A.W., Mesenteric lymph node hemangiomas of Wistar rats. Toxicol. Pathol. 20 (1992), 268–273.
36. Sakurai, Y., Shoji, M., Matsubara, T., Imazu, H., Hasegawa, S., Ochiai, M., Funabiki, T., Mizoguchi, Y., Kuroda, M., Kasahara, M., Angiomyomatous hamartoma and associated stromal lesions in the right inguinal lymph node: a case report. Pathol. Int. 50 (2000), 655–659.
37. Samet, A., Gilbey, P., Talmon, Y., Cohen, H., Vascular transformation of lymph node sinuses. J. Laryngol. Otol. 115 (2001), 760–762.
38. Som, P.M., Brandwein, M.S., Lymph nodes. Som, P.M., Curtin, H.D., (eds.) Head and Neck Imaging, 4th ed., 2003, Mosby, Maryland Heights, MO, 1866–1868 Chapter 36.
39. Steinmann, G., Földi, E., Földi, M., Racz, P., Lennert, K., Morphologic findings in lymph nodes after occlusion of their efferent lymphatic vessels and veins. Lab. Invest. 47 (1982), 43–50.
40. Tennekes, H., Kaufmann, W., Dammann, M., van Ravenzwaay, B., The stability of historical control data for common neoplasms in laboratory rats and the implications for carcinogenic risk assessment. Regul. Toxicol. Pharmacol. 40 (2004), 293–304.
41. Tucker, M.J., The haematopoietic and lymphatic systems. Diseases of the Wistar Rat, 2003, Taylor & Francis Inc., Bristol, PA pp. 135–136.
42. Usui, T., Mutai, M., Hisada, S., Takoaka, M., Soper, K.A., McCullough, B., Alden, C.A., CB6F1–rasH2 mouse: overview of available data. Toxicol. Pathol. 29 (2001), 90–108.
43. Watanabe, T., Kashida, Y., Yasuhara, K., Koujitani, T., Hirose, M., Mitsumori, K., Rapid induction of uterine endometrial proliferative lesions in transgenic mice carrying a human prototype c-Ha-ras gene (rasH2 mice) given a single intraperitoneal injection of N-ethyl-N-nitrosourea. Cancer Lett. 188 (2002), 39–46.
44. Weiss, S.W., Goldblum, J.R., Malignant vascular tumors. Weis, S.W., Goldblum, J.R., (eds.) Enzinger and Weiss's Soft Tissue Tumors, 5th ed., 2008, Mosley Elsevier, China, 703–732.
45. Zadvinskis, D.P., Benson, M.T., Kerr, H.H., Mancuso, A.A., Cacciarelli, A.A., Madrazo, B.L., Mafee, M.F., Dalen, K., Congenital malformations of the cervicothoracic lymphatic system: embryology and pathogenesis. RadioGraphics 12 (1992), 1175–1189.
46. Zwicker, G.M., Eyster, R.C., Sells, D.M., Gass, J.H., Spontaneous vascular neoplasms in aged Sprague–Dawley rats. Toxicol. Pathol. 23 (1995), 518–526.